Jaguar Health (JAGX) Capital Expenditures Growth (3y) (2018 - 2026)
Jaguar Health (JAGX) Capital Expenditures Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | -12.25% |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn | 46.88% |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn | 8.97% |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn | 16.27% |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - | - |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn | -59.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.47% |
| Dec 31, 2025 | 2.36% |
| Sep 30, 2025 | -8.81% |
| Dec 31, 2024 | -110.49% |
| Jun 30, 2024 | 246.29% |
| Mar 31, 2024 | -244.35% |
| Mar 31, 2023 | 37.00% |
| Jun 30, 2022 | 226.10% |
| Mar 31, 2022 | 29.77% |
| Dec 31, 2021 | 29.10% |
| Mar 31, 2021 | -68.19% |
| Jun 30, 2019 | 39.43% |
| Mar 31, 2019 | -32.29% |
| Dec 31, 2018 | -42.04% |